CIK 0001818838 · Accelerated filer<br>Emerging growth company
Adagene Inc.
Sign in to watch- Ticker
- ADAG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- other
- Phone
- 86-512-87773632
- Business address
- 4F, BUILDING C14, NO. 218, XINGHU STREET, SUZHOU INDUSTRIAL PARK, JIANGSU, China, 00000
- Open-market buys, last 90 days
- $77,480
- in 3 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$77,480. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-23 | Tam Man Kin Chief Financial Officer | Purchase | +2,000 | $3.00 | $6K | 12,000 |
| 2026-09-16 | Luo Peter Chief Executive Officer | Purchase | +20,290 | $3.15 | $64K | 88,535 |
| 2026-08-14 | DO CUONG V Director | Purchase | +2,000 | $3.75 | $8K | 2,000 |
| 2026-08-13 | Zhu Li Director | Grant or award · Nonqualified Stock Option (Right to Buy) | +20,000 | 90,000 | ||
| 2026-08-13 | Cheung Andy Yiu Leung Director | Grant or award · Nonqualified Stock Option (Right to Buy) | +20,000 | 90,000 | ||
| 2026-08-13 | DO CUONG V Director | Grant or award · Nonqualified Stock Option (Right to Buy) | +20,000 | 110,000 | ||
| 2026-08-13 | Grawunder Ulf Director | Grant or award · Nonqualified Stock Option (Right to Buy) 10b5-1 | +20,000 | 85,000 | ||
| 2026-08-05 | Luo Peter Chief Executive Officer | Purchase | +279 | $3.65 | $1K | 68,245 |
| 2026-08-04 | Luo Peter Chief Executive Officer | Purchase | +22,966 | $3.65 | $84K | 67,966 |
Page 1 of 1 · 9 trades